(Q42469275)

English

Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

triclabendazole

1 reference

based on heuristic

inferred from title

Fasciola hepatica

object named as

Fasciola hepatica

1 reference

based on heuristic

inferred from title

author name string

Catherine Devine

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Gerard P Brennan

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Carlos E Lanusse

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Luis I Alvarez

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Alan Trudgett

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Elizabeth Hoey

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Ian Fairweather

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

25 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Parasitology Research

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1351-1363

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

https://scigraph.springernature.com/pub.10.1007/s00436-010-1806-1

0 references

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-010-1806-1

21 January 2018

Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methimazole-mediated modulation of netobimin biotransformation in sheep: a pharmacokinetic assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triclabendazole progress report, 2005-2009: an advancement of learning?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics and metabolism of ivermectin in domestic animal species.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triclabendazole: new skills to unravel an old(ish) enigma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: Ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphencthide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The kinetics of triclabendazole disposition in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: Basal infolds and associated vacuoles of the tegument

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: tegumental alterations as a consequence of lectin binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen').

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence on the antithyroid compound methimazole on the plasma disposition of fenbendazole and oxfendazole in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of methimazole on the kinetics of netobimin metabolites in cattle

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interaction between the deacetylated (amine) metabolite of diamphenethide (DAMD) and cytochemically demonstrable Na+/K+-ATPase activity in the tegument of Fasciola hepatica

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep

1 reference

https://pubmed.ncbi.nlm.nih.gov/20336319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00436-010-1806-1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42469275&oldid=1958566686"